Literature DB >> 32970531

Mapping Transplant Arteriosclerosis Cell-by-Cell: A Path to New Immune Insights.

Dawn M Fernandez1, Chiara Giannarelli1,2.   

Abstract

Entities:  

Keywords:  Editorials; allografts; arteriosclerosis; immune system; stem cells; tissue survival; transplants

Mesh：

Year:  2020        PMID： 32970531      PMCID： PMC7518471          DOI： 10.1161/CIRCRESAHA.120.317907

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  15 in total

1.  Successful homotransplantation of the human kidney between identical twins.

Authors:  J P MERRILL; J E MURRAY; J H HARRISON; W R GUILD
Journal:  J Am Med Assoc       Date:  1956-01-28

Review 2.  Graft vascular disease: immune response meets the vessel wall.

Authors:  Richard N Mitchell
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

3.  Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice.

Authors:  Filip K Swirski; Moritz Wildgruber; Takuya Ueno; Jose-Luiz Figueiredo; Peter Panizzi; Yoshiko Iwamoto; Elizabeth Zhang; James R Stone; Elisenda Rodriguez; John W Chen; Mikael J Pittet; Ralph Weissleder; Matthias Nahrendorf
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

4.  Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.

Authors:  Antti I Nykänen; Henrik Sandelin; Rainer Krebs; Mikko A I Keränen; Raimo Tuuminen; Terhi Kärpänen; Yan Wu; Bronislaw Pytowski; Petri K Koskinen; Seppo Ylä-Herttuala; Kari Alitalo; Karl B Lemström
Journal:  Circulation       Date:  2010-03-15       Impact factor: 29.690

Review 5.  Allograft vasculopathy versus atherosclerosis.

Authors:  Maziar Rahmani; Rani P Cruz; David J Granville; Bruce M McManus
Journal:  Circ Res       Date:  2006-10-13       Impact factor: 17.367

6.  An overview of immunosuppression in solid organ transplantation.

Authors:  Cher Enderby; Cesar A Keller
Journal:  Am J Manag Care       Date:  2015-01       Impact factor: 2.229

7.  Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis.

Authors:  Clément Cochain; Ehsan Vafadarnejad; Panagiota Arampatzi; Jaroslav Pelisek; Holger Winkels; Klaus Ley; Dennis Wolf; Antoine-Emmanuel Saliba; Alma Zernecke
Journal:  Circ Res       Date:  2018-03-15       Impact factor: 17.367

8.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.

Authors:  Peter Duewell; Hajime Kono; Katey J Rayner; Cherilyn M Sirois; Gregory Vladimer; Franz G Bauernfeind; George S Abela; Luigi Franchi; Gabriel Nuñez; Max Schnurr; Terje Espevik; Egil Lien; Katherine A Fitzgerald; Kenneth L Rock; Kathryn J Moore; Samuel D Wright; Veit Hornung; Eicke Latz
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

9.  Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy.

Authors:  Rong Yin; Jiaquan Zhu; Hongtao Shao; Xiaofeng Cheng; Xiaomei Feng; Zhongdong Li; Hua Jing
Journal:  J Heart Lung Transplant       Date:  2007-05       Impact factor: 10.247

10.  Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients.

Authors:  Alexandru Schiopu; Satish N Nadig; Ovidiu S Cotoi; Joanna Hester; Nico van Rooijen; Kathryn J Wood
Journal:  Atherosclerosis       Date:  2012-05-19       Impact factor: 5.162
View more
  1 in total

Review 1.  Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation.

Authors:  Charlotte Domblides; Juliette Rochefort; Clémence Riffard; Marylou Panouillot; Géraldine Lescaille; Jean-Luc Teillaud; Véronique Mateo; Marie-Caroline Dieu-Nosjean
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.